Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.71 |
| ▸ | THPO | P40225 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.69 |
| ▸ | ABCB1 | P08183 | 14/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.46 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7860449 | 0.87 | CYP2D6 (0.67) | CYP2D6THPOLMNAPMP22ABCB1 | |
| SCHEMBL6021254 | 0.83 | CYP2D6 (1.00) | CYP2D6THPOLMNAPMP22ABCB1 | |
| SCHEMBL19944416 | 0.82 | DRD2 (0.61) | CYP2D6THPOLMNAPMP22SIGMAR1 | |
| SCHEMBL7862476 | 0.82 | ABCB1 (0.65) | LMNAABCB1KDM4EALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL2001258 | 0.82 | LMNA (1.00) | CYP2D6THPOLMNAPMP22ABCB1 | |
| SCHEMBL12618637 | 0.82 | CYP2D6 (0.74) | CYP2D6THPOLMNAPMP22ABCB1 | |
| SCHEMBL7703424 | 0.79 | CYP2D6 (0.79) | CYP2D6THPOLMNAPMP22ABCB1 | |
| SCHEMBL7854831 | 0.78 | LMNA (0.58) | CYP2D6THPOLMNAPMP22KDM4E | |
| SCHEMBL8909812 | 0.77 | CYP2D6 (0.49) | CYP2D6THPOLMNAPMP22ABCB1 | |
| SCHEMBL7854934 | 0.76 | LMNA (0.67) | CYP2D6THPOLMNAPMP22KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0837680-B1 | USE OF PHENOXY PYRIDINE DERIVATIVES FOR THE TREATMENT OF ILLNESSES CAUSED BY DISORDERS OF THE DOPAMINE SYSTEM | HOFFMANN LA ROCHE (CH) | 2001-01-31 | — | — | EP | claimed |
| EP-0837680-A1 | USE OF PHENOXY PYRIDINE DERIVATIVES FOR THE TREATMENT OF ILLNESSES CAUSED BY DISORDERS OF THE DOPAMINE SYSTEM | F. HOFFMANN-LA ROCHE AG (CH) | 1998-04-29 | — | — | EP | claimed |
| US-5698565-A | TREATMENT OF PSYCHOTIC DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 1997-12-16 | — | — | US | claimed |
| WO-1996041629-A1 | USE OF PHENOXY PYRIDINE DERIVATIVES FOR THE TREATMENT OF ILLNESSES CAUSED BY DISORDERS OF THE DOPAMINE SYSTEM | F. HOFFMANN-LA ROCHE AG (CH) | 1996-12-27 | — | — | WO | claimed |
| EP-0837680-B1 | USE OF PHENOXY PYRIDINE DERIVATIVES FOR THE TREATMENT OF ILLNESSES CAUSED BY DISORDERS OF THE DOPAMINE SYSTEM | HOFFMANN LA ROCHE (CH) | 2001-01-31 | — | — | EP | disclosed |
| EP-0837680-A1 | USE OF PHENOXY PYRIDINE DERIVATIVES FOR THE TREATMENT OF ILLNESSES CAUSED BY DISORDERS OF THE DOPAMINE SYSTEM | F. HOFFMANN-LA ROCHE AG (CH) | 1998-04-29 | — | — | EP | disclosed |
| WO-1996041629-A1 | USE OF PHENOXY PYRIDINE DERIVATIVES FOR THE TREATMENT OF ILLNESSES CAUSED BY DISORDERS OF THE DOPAMINE SYSTEM | F. HOFFMANN-LA ROCHE AG (CH) | 1996-12-27 | — | — | WO | disclosed |